Business Wire

Fluidigm Introduces Fast 192.24 Dynamic Array IFC for Genotyping

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, ...
technologynetworks

Quantitative miRNA Expression Analysis Using Fluidigm Microfluidics Dynamic Arrays

BACKGROUND: MicroRNAs (miRNAs) represent a growing class of small non-coding RNAs that are important regulators of gene expression in both plants and animals. Studies have shown that miRNAs play a ...
Business Wire

Fluidigm Introduces Its Most Advanced Genomic Analysis System – The BioMark™ HD Real-Time PCR System

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm today introduced the new BioMark™ HD Real-time PCR System, the company’s most advanced instrument for genomic analysis ever. The BioMark HD ...
GEN

Oncomed to Exploit Fluidigm’s Microfluidic Devices in Cancer Stem Cell Research

Collaboration will perform gene-expression analysis of tumors and evaluate changes in cancer stem cells when mAbs are used. OncoMed Pharmaceuticals is tapping Fluidigm’s microfluidic tools for the ...
FiercePharma

Roche and Fluidigm Corporation Enter Worldwide Co-Promotion Agreement for 454 Sequencing Systems and Access Array™ Platfor

BRANFORD, Conn. & SAN FRANCISCO--(BUSINESS WIRE)-- 454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the ...